The global 3D cell culture market is projected to reach USD 3,319.43 Billion by 2028, driven by factors such as government and non-government investments in cancer research and development, increasing popularity of regenerative medicine, growing demand for organ transplantation, and rising patients of oncological diseases.
The market is segmented based on technology into scaffold-based, scaffold-free, and 3D bioreactors, with scaffold-free techniques projected to witness the highest growth rate of 12.3% during the forecast period. The market is also segmented based on application into cancer, tissue engineering & immunohistochemistry, drug development, stem cell research, and others, with stem cell research applications projected to have the highest CAGR of 12.5%.
The market is further segmented based on end-users into biotechnology and pharmaceutical industries, research laboratories and institutes, hospitals and diagnostic centers, and others, with the research laboratories and institutes segment projected to have the highest CAGR of 13.2%.
Get a Free Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/1333
The Asia Pacific region is expected to witness the highest growth rate of 11.7% during the forecast period owing to the developing healthcare and pharmaceutical industry in this region.
Key participants in the market include Advanced Biomatrix, 3D Biotek, Corning Incorporated, Becton and Dickinson Company (BD), Thermo Fisher Scientific Inc., Global cell solutions Inc., Nanofiber solutions, VWR Corporation, Synthecon incorporated, Lonza Group Ltd., and Tecan Trading AG., among others.
0 Comments
Post a Comment